These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27012708)

  • 1. ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway and suppresses tumor growth in hepatocellular carcinoma cells.
    Baik SH; Lee J; Lee YS; Jang JY; Kim CW
    Exp Mol Med; 2016 Mar; 48(3):e222. PubMed ID: 27012708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
    Jang JY; Lee YS; Jeon YK; Lee K; Jang JJ; Kim CW
    Exp Mol Med; 2013 Jan; 45(1):e3. PubMed ID: 23306701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANT2 suppression by shRNA may be able to exert anticancer effects in HCC further by restoring SOCS1 expression.
    Jang JY; Jeon YK; Lee CE; Kim CW
    Int J Oncol; 2013 Feb; 42(2):574-82. PubMed ID: 23242177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined RNA interference of adenine nucleotide translocase-2 and ganciclovir therapy in hepatocellular carcinoma.
    Kim JE; Hwang MH; Lee HW; Lee SW; Lee J; Ahn BC
    Nucl Med Biol; 2013 Nov; 40(8):987-93. PubMed ID: 24054501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma.
    Lu AQ; Lv B; Qiu F; Wang XY; Cao XH
    Oncol Rep; 2017 Apr; 37(4):2071-2078. PubMed ID: 28350139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
    Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulation.
    Jiang J; Zhang Y; Guo Y; Yu C; Chen M; Li Z; Tian S; Sun C
    Oncotarget; 2015 Mar; 6(8):6359-72. PubMed ID: 25849943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway.
    Yang F; Gong J; Wang G; Chen P; Yang L; Wang Z
    Oncotarget; 2016 Nov; 7(46):75165-75175. PubMed ID: 27738335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.
    Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
    Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells.
    Jang JY; Jeon YK; Kim CW
    BMC Cancer; 2010 Jul; 10():391. PubMed ID: 20650008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
    Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H
    Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-424 inhibits Akt3/E2F3 axis and tumor growth in hepatocellular carcinoma.
    Yang H; Zheng W; Shuai X; Chang RM; Yu L; Fang F; Yang LY
    Oncotarget; 2015 Sep; 6(29):27736-50. PubMed ID: 26315541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-324-5p Suppresses Hepatocellular Carcinoma Cell Invasion by Counteracting ECM Degradation through Post-Transcriptionally Downregulating ETS1 and SP1.
    Cao L; Xie B; Yang X; Liang H; Jiang X; Zhang D; Xue P; Chen D; Shao Z
    PLoS One; 2015; 10(7):e0133074. PubMed ID: 26177288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
    Gao M; Liu L; Li S; Zhang X; Chang Z; Zhang M
    Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.